当前位置:首页 - 行情中心 - 康弘药业(002773) - 财务分析 - 现金流量表

康弘药业

(002773)

  

流通市值:211.75亿  总市值:284.04亿
流通股本:6.87亿   总股本:9.21亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,867,965,865.992,569,837,866.61,208,720,347.24,786,194,043.99
  收到的税费返还---2,552,375.17
  收到其他与经营活动有关的现金118,373,151.6778,317,067.0433,056,888.1359,335,931.39
  经营活动现金流入小计3,986,339,017.662,648,154,933.641,241,777,235.334,848,082,350.55
  购买商品、接受劳务支付的现金209,154,428.35137,231,441.8560,770,871.49371,551,364.07
  支付给职工以及为职工支付的现金1,001,232,591.36661,230,983.58368,316,172.691,186,324,970.01
  支付的各项税费329,038,713.95244,126,567.0799,124,228.43403,087,500.23
  支付其他与经营活动有关的现金1,038,637,595.98689,779,620.04280,488,066.281,475,243,678.51
  经营活动现金流出小计2,578,063,329.641,732,368,612.54808,699,338.893,436,207,512.82
  经营活动产生的现金流量净额1,408,275,688.02915,786,321.1433,077,896.441,411,874,837.73
二、投资活动产生的现金流量:
  收回投资收到的现金3,240,000,0002,640,000,000-4,330,790,000
  取得投资收益收到的现金11,533,310.238,353,588.76-47,711,305.69
  处置固定资产、无形资产和其他长期资产收回的现金净额77,489.7653,154.6618,814.36548,764
  收到的其他与投资活动有关的现金860,000600,000330,0001,014,000
  投资活动现金流入小计3,252,470,799.992,649,006,743.42348,814.364,380,064,069.69
  购建固定资产、无形资产和其他长期资产支付的现金179,453,898.1174,295,030.4947,274,476.51159,390,322.05
  投资支付的现金5,805,000,0005,305,000,0002,640,000,0004,330,790,000
  支付其他与投资活动有关的现金650,000430,000226,0001,940,000
  投资活动现金流出小计5,985,103,898.115,379,725,030.492,687,500,476.514,492,120,322.05
  投资活动产生的现金流量净额-2,732,633,098.12-2,730,718,287.07-2,687,151,662.15-112,056,252.36
三、筹资活动产生的现金流量:
  吸收投资收到的现金35,047,48529,342,742.5270,0006,748,052.1
  其中:子公司吸收少数股东投资收到的现金1,810,000270,000270,000-
  筹资活动现金流入小计35,047,48529,342,742.5270,0006,748,052.1
  分配股利、利润或偿付利息支付的现金552,673,862.4552,673,862.4-349,396,302.52
  支付其他与筹资活动有关的现金1,485,890.361,617,120.151,476,919.361,491,045.53
  筹资活动现金流出小计554,159,752.76554,290,982.551,476,919.36350,887,348.05
  筹资活动产生的现金流量净额-519,112,267.76-524,948,240.05-1,206,919.36-344,139,295.95
四、汇率变动对现金及现金等价物的影响-551,595.52-2,359.72-366,606.53-246,263.46
五、现金及现金等价物净增加额-1,844,021,273.38-2,339,882,565.74-2,255,647,291.6955,433,025.96
  加:期初现金及现金等价物余额5,625,427,246.565,625,427,246.565,625,427,246.564,669,994,220.6
  期末现金及现金等价物余额3,781,405,973.183,285,544,680.823,369,779,954.965,625,427,246.56
补充资料:
  净利润-721,864,033.83-1,177,008,069.02
  资产减值准备-1,199,917.99-1,943,889.29
  固定资产和投资性房地产折旧-99,096,017.62-197,382,035.6
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-99,096,017.62-197,382,035.6
  无形资产摊销-16,672,349.14-31,758,036.56
  长期待摊费用摊销-1,979,204.7-3,983,537.52
  处置固定资产、无形资产和其他长期资产的损失--3,472.82--14,202.59
  固定资产报废损失-257,117.33-1,322,725.15
  公允价值变动损失-1,884,200-1,056,000
  财务费用-317,709.81-317,686.92
  投资损失--8,123,311.62--47,277,710.26
  递延所得税-80,711,773.66-103,708,268.48
  其中:递延所得税资产减少-83,580,674.79-98,619,543.82
    递延所得税负债增加--2,868,901.13-5,088,724.66
  存货的减少-12,793,834.18-13,789,722.46
  经营性应收项目的减少--33,799,903.82--45,745,744.42
  经营性应付项目的增加-17,438,381.06--30,378,010.37
  其他-2,600,399.42-1,746,476.54
  现金的期末余额-3,285,544,680.82-5,625,427,246.56
  减:现金的期初余额-5,625,427,246.56-4,669,994,220.6
  现金及现金等价物的净增加额--2,339,882,565.74-955,433,025.96
公告日期2025-10-292025-08-282025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑